Arizona State Retirement System Alaunos Therapeutics, Inc. Transaction History

Arizona State Retirement System

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$0.41 - $1.24 $23,955 - $72,450	-58,428 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$0.62 - $1.17 $254 - $480	411 Added 0.71%	58,428 $38,000
Q4 2021 Feb 04, 2022	SELL	$1.09 - $1.89 $752 - $1,304	-690 Reduced 1.18%	58,017 $63,000
Q3 2021 Nov 12, 2021	BUY	$1.44 - $2.73 $658 - $1,247	457 Added 0.78%	58,707 $107,000
Q2 2021 Aug 02, 2021	SELL	$2.63 - $3.67 $10,861 - $15,157	-4,130 Reduced 6.62%	58,250 $154,000
Q1 2021 May 06, 2021	BUY	$2.82 - $5.6 $778 - $1,545	276 Added 0.44%	62,380 $225,000
Q4 2020 Jan 28, 2021	SELL	$2.09 - $3.09 $5,337 - $7,891	-2,554 Reduced 3.95%	62,104 $157,000
Q3 2020 Nov 05, 2020	BUY	$2.39 - $3.43 $41,868 - $60,086	17,518 Added 37.16%	64,658 $163,000
Q2 2020 Aug 04, 2020	SELL	$2.2 - $3.71 $4,162 - $7,019	-1,892 Reduced 3.86%	47,140 $155,000
Q1 2020 May 05, 2020	BUY	$1.9 - $4.98 $93,160 - $244,179	49,032 New	49,032 $120,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $672M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.